Rev Genomics Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Rev Genomics's estimated annual revenue is currently $930k per year.(i)
  • Rev Genomics's estimated revenue per employee is $155,000

Employee Data

  • Rev Genomics has 6 Employees.(i)
  • Rev Genomics grew their employee count by 0% last year.

Rev Genomics's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Rev Genomics?

We are an Oakland, California, plant biotechnology company utilizing cutting edge breeding tools for high-value crops. Our toolkit includes whole genome selection, advanced tissue culture, molecular genetics and in-house metabolite analytics. With our scientific approach to Cannabis strain development we have created new strains now being commercialized in the legal California market. We are backed by Y-Combinator and our platform has been featured in TechCrunch.

keywords:N/A

N/A

Total Funding

6

Number of Employees

$930k

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Rev Genomics News

2022-04-19 - The Cycas genome and the early evolution of seed plants

The Cycas genome contains four homologues of the fitD gene family that were likely acquired via horizontal gene transfer from ... Plant Rev.

2022-04-06 - Metagenomics-enabled microbial surveillance

The use of whole-genome sequencing (WGS) for bacteria, ... E. E. Long-read human genome sequencing and its applications. Nat. Rev. Genet.

2022-04-06 - A joint NCBI and EMBL-EBI transcript set for clinical genomics ...

Miga, K. H. & Wang, T. The need for a human pangenome reference sequence. Annu. Rev. Genomics Hum. Genet. 22, 81–102 (2021). Article CAS...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.4M60%N/A
#2
$0.4M6-14%N/A
#3
$0.4M6-14%N/A
#4
$0.4M6-14%N/A
#5
$0.4M60%N/A